secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2025-09-23T23:59:59+00:00
Accession:  0001493152-25-014684
Event type: other
Sentiment:  positive
Materiality: 0.55
Item codes: 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma series L preferred holders waive redemption rights permanently
---------------------------------------------------------------------------

- Holders of Series L 10% Convertible Preferred Stock waived redemption rights under Section 10 of the Certificate of Designations.
- Waivers were provided on September 17, 18, and 23, 2025, and are permanent.
- Waiver does not affect other rights of the preferred stockholders under the Certificate of Designations.
- The company requested the waiver; certain holders countersigned the form of waiver.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315225014684/0001493152-25-014684-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315225014684/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-014684

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer